🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this investigation is to compare the use of bone marrow aspirate...
Status
Completed
Location
New York University School of Medicine
Start Date
2018-07-24
Trial ID
NCT02924571
The main objective of this study was to assess the safety profile of MBG453...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2022-03-17
Trial ID
NCT04878432
Treatments Being Tested
To evaluate whether percutaneous coronary intervention (PCI) with contempor...
Status
Not Yet Recruiting
Location
Nanjing First Hospital, Nanjing Medical University
Start Date
2026-12-30
Trial ID
NCT07349979
Treatments Being Tested
The goal of the ADEPT Study is to understand anhedonia in young people and ...
Status
Completed
Location
Loeffler Building
Start Date
2022-07-22
Trial ID
NCT05487885
PRE-EMPT will assemble a cohort of 150 participants from three populations ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07745569
Treatments Being Tested
Open-label, dose escalation (Phase I) and dose expansion (Phase IIA) study ...
Status
Completed
Location
Honor Health
Start Date
2019-09-23
Trial ID
NCT04020185
Treatments Being Tested
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
Background: Myelodysplastic syndromes (MDS) are diseases that affect the b...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2023-11-14
Trial ID
NCT05918055
Treatments Being Tested
This study is a multicenter, three-part study. Parts 1 and 2 are randomized...
Status
Completed
Location
Royal Brisbane and Women's Hospital
Start Date
2016-12-14
Trial ID
NCT02952924
This is a Phase 1, randomized, open label, 4-period, 6-sequence, partial cr...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2017-09-11
Trial ID
NCT03112148
Treatments Being Tested